Oran Baris
Oran Baris's purchase track record
Oran Baris has no open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/11/2026 | AMRZ | $284K | pending | pending | — |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
GXO Logistics Schedules Earnings Call and Announces New Partnerships. GXO Logistics has set the date for its third‑quarter 2026 earnings conference call on November 4. The company also disclosed expanded logistics outsourcing agreements with Puma and Columbia, adding to its service portfolio. Analysts note the recent supply‑chain deal and a new 10‑year contract in Europe may affect valuation, while a research note kept a positive outlook but lowered the price target to $60.
Transaction History
| AMRZ | ▲ Buy | Open Market | 3,000 | $141K | 8/12/2026 | View on chart |
| AMRZ | ▲ Buy | Open Market | 3,000 | $142K | 8/11/2026 | View on chart |
| GXO | ▼ Sell | Tax Withholding | 5,273 | $294K | 3/9/2026 | View on chart |
| GXO | ▲ Buy | Option Exercise | 4,921 | $0 | 3/7/2026 | View on chart |
| GXO | ▲ Buy | Option Exercise | 2,692 | $0 | 3/7/2026 | View on chart |
| GXO | ▲ Buy | Option Exercise | 3,763 | $0 | 3/7/2026 | View on chart |
| GXO | ▲ Buy | Option Exercise | 16,540 | $0 | 1/15/2026 | View on chart |
| GXO | ▼ Sell | Tax Withholding | 7,811 | $445K | 1/15/2026 | View on chart |
| GXO | ▲ Buy | Option Exercise | 12,500 | $0 | 4/1/2025 | View on chart |
| GXO | ▲ Buy | Option Exercise | 1,875 | $0 | 4/1/2025 | View on chart |
| GXO | ▼ Sell | Tax Withholding | 6,662 | $260K | 4/1/2025 | View on chart |
| GXO | ▲ Buy | Option Exercise | 2,691 | $0 | 3/7/2025 | View on chart |
| GXO | ▲ Buy | Option Exercise | 3,762 | $0 | 3/7/2025 | View on chart |
| GXO | ▼ Sell | Tax Withholding | 3,059 | $117K | 3/7/2025 | View on chart |
| GXO | ▲ Buy | Option Exercise | 12,500 | $0 | 4/1/2024 | View on chart |
| GXO | ▲ Buy | Option Exercise | 1,875 | $0 | 4/1/2024 | View on chart |
| GXO | ▼ Sell | Tax Withholding | 6,662 | $358K | 4/1/2024 | View on chart |
| GXO | ▲ Buy | Option Exercise | 2,692 | $0 | 3/7/2024 | View on chart |
| GXO | ▼ Sell | Tax Withholding | 920 | $46K | 3/7/2024 | View on chart |
| GXO | ▲ Buy | Option Exercise | 1,875 | $0 | 4/1/2023 | View on chart |
| GXO | ▼ Sell | Tax Withholding | 869 | $44K | 4/1/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
JP Morgan cuts Amrize price target to $48, maintains Neutral
JP Morgan has lowered its price target for Amrize to $48 while keeping a Neutral rating. This move comes as the company prepares to announce its third-quarter 2026 financial results. Recent reports also highlight the firm's regional scale and pricing power, though the current analyst target sits below the average consensus of $47.20.
JP Morgan cuts Amrize price target to $48, maintains Neutral. JP Morgan has lowered its price target for Amrize to $48 while keeping a Neutral rating. This move comes as the company prepares to announce its third-quarter 2026 financial results. Recent reports also highlight the firm's regional scale and pricing power, though the current analyst target sits below the average consensus of $47.20.